Alimohammadi, A., Kiani, G., Raycraft, T., Shahi, R., Singh, A., & Conway, B. (2018). A181 REAL-LIFE EFFICACY OF ELBASVIR/GRAZOPREVIR (EBV/GZV) FOR THE TREATMENT OF CHRONIC HCV GENOTYPE 1 AND 3 INFECTION. J Can Assoc Gastroenterol.
Citação norma ChicagoAlimohammadi, A., G. Kiani, T. Raycraft, R. Shahi, A. Singh, and B. Conway. "A181 REAL-LIFE EFFICACY OF ELBASVIR/GRAZOPREVIR (EBV/GZV) FOR THE TREATMENT OF CHRONIC HCV GENOTYPE 1 AND 3 INFECTION." J Can Assoc Gastroenterol 2018.
MLA citiranjeAlimohammadi, A., et al. "A181 REAL-LIFE EFFICACY OF ELBASVIR/GRAZOPREVIR (EBV/GZV) FOR THE TREATMENT OF CHRONIC HCV GENOTYPE 1 AND 3 INFECTION." J Can Assoc Gastroenterol 2018.
Opozorilo: Ti citati niso vedno 100% točni.